Mitochondrial signalling: MOTS-c is the only compound in the group targeting the AMPK/SIRT3 axis, addressing the metabolic driver of epithelial dysfunction
Research protocols typically administer doses in the morning on an empty stomach to avoid food-mediated absorption interference, though no published studies have directly tested fed versus fasted states for 5-amino-1mq specifically
Low-dose naltrexone (LDN) has emerged as one of the most promising agents in this area, working through glial cell modulation to reduce neuroinflammation and through toll-like receptor pathways to quiet abnormal immune activation
Itching or a mild rash may occur rarely
Wang X-Y, Qu M, Duan R, Shi D, Jin L, Gao J, et al
A comprehensive metabolic panel and complete blood count provide useful baseline data